Kathy-Ann Secker - JoVE Visualize

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

Frontiers in Immunology|July 30, 2019

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote <i>ex vivo</i> Lysis of Leukemic Blasts in a CD1d-Dependent MannerSimona Jahnke, Hannes Schmid, Kathy-Ann Secker, et al.

Journal for Immunotherapy of Cancer|January 31, 2024

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivityEmmanuelle Moraes Ribeiro, Kathy-Ann Secker, Ana-Maria Nitulescu, et al.

Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

Frontiers in Immunology|July 30, 2019

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote <i>ex vivo</i> Lysis of Leukemic Blasts in a CD1d-Dependent MannerSimona Jahnke, Hannes Schmid, Kathy-Ann Secker, et al.

Journal for Immunotherapy of Cancer|January 31, 2024

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivityEmmanuelle Moraes Ribeiro, Kathy-Ann Secker, Ana-Maria Nitulescu, et al.

Pageof 2